M6620 First in Human Study

PHASE1CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 10, 2012

Primary Completion Date

March 11, 2020

Study Completion Date

March 11, 2020

Conditions
Advanced Solid Tumor
Interventions
DRUG

M6620

DRUG

Gemcitabine

DRUG

Cisplatin

DRUG

Etoposide

DRUG

Carboplatin

DRUG

Irinotecan

Trial Locations (31)

11042

Long Island Jewish Medical Center - Monter Cancer Center, Lake Success

22031

Virginia Cancer Specialists, PC, Fairfax

23502

Virginia Oncology Associates - Hampton, Norfolk

29605

Greenville Health System, Greenville

30322

Emory University, Atlanta

37232

Vanderbilt University Medical Center, Nashville

43210

OSU - James Comprehensive Cancer Center - Division of Hematology, Columbus

44106

University Hospitals Case Medical Center - Case Comprehensive Cancer Center at, Cleveland

48910

Breslin Cancer Center, Lansing

55455

University Of Minnesota Hospital, Minneapolis

55905

Mayo Clinic - Rochester, Rochester

60611

Northwestern Center for Clinical Research, Chicago

63110

Washington University in St. Louis, St Louis

75231

Texas Oncology, P.A., Dallas

77030

University of Texas M. D. Anderson Cancer Center - Investigational Cancer Therapeutics - Partner, Houston

78240

Texas Oncology San Antonio Medical Cente, San Antonio

78705

US Oncology - Texas Oncology-Midtown - Austin Midtown, Austin

80218

Rocky Mountain Cancer Centers, LLP, Denver

85054

Mayo Clinic Arizona, Phoenix

92123

Sharp Memorial Hospital, San Diego

98684

Northwest Cancer Specialists , P.C., Vancouver

Unknown

Stanford

Freeman Hospital - PARENT, Newcastle upon Tyne

Churchill Hospital - PARENT, Oxford

Beatson West of Scotland Cancer Centre - Dept of Medical Oncology, Glasgow

Royal Marsden Hospital - Dept of Oncology, Sutton

Guy's Hospital - PARENT, London

Sarah Cannon Research Institute UK, London

The Christie - Dept of Oncology, Manchester

02215

Dana Farber Cancer Institute, Boston

07601

Hackensack University Medical Center PARTNER, Hackensack

All Listed Sponsors
collaborator

Merck KGaA, Darmstadt, Germany

INDUSTRY

lead

EMD Serono Research & Development Institute, Inc.

INDUSTRY

NCT02157792 - M6620 First in Human Study | Biotech Hunter | Biotech Hunter